logo-loader
viewXPhyto Therapeutics Corp.

XPhyto kicks off exclusive partnership with brewing institute Weihenstephan

XPhyto Therapeutics (CSE: XPHY-FSE:4XT) CEO Hugh Rogers sat down with Steve Darling from Proactive Vancouver to discuss an agreement with the brewing and beverage institute within the Technical University of Munich.  Rogers reviews the structure of the deal and also talks about an agreement with Colombian cannabis giant PharmaCielo. 

Quick facts: XPhyto Therapeutics Corp.

Price: 3.3 CAD

CSE:XPHY
Market: CSE
Market Cap: $179.04 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of XPhyto Therapeutics Corp. named herein, including the promotion by the Company of XPhyto Therapeutics Corp. in any Content on the Site, the...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

XPhyto Therapeutics partner 3A revives grant from German Ministry of...

XPhyto (CSE: XPHY- OTC: XPHYF) CEO Hugh Rogers joined Steve Darling from Proactive Vancouver to bring news their German partner 3aDiagnostics and their contract research collaborators, have received a grant from the German Federal Ministry of Education and Research. Roger telling Proactive...

on 12/6/20

2 min read